Clover Health Investments, Corp.
CLOV
$4.60
$0.112.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.86% | 53.17% | |||
| Total Other Revenue | 8.00% | 172.48% | |||
| Total Revenue | -0.80% | 53.61% | |||
| Cost of Revenue | 0.09% | 42.60% | |||
| Gross Profit | -4.10% | 114.99% | |||
| SG&A Expenses | -5.51% | 6.97% | |||
| Depreciation & Amortization | 9.51% | 22.62% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.93% | 34.42% | |||
| Operating Income | 2.44% | 155.42% | |||
| Income Before Tax | 2.44% | 155.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.44% | 155.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.44% | 155.42% | |||
| EBIT | 2.44% | 155.42% | |||
| EBITDA | 2.57% | 156.95% | |||
| EPS Basic | 2.10% | 154.82% | |||
| Normalized Basic EPS | 2.14% | 154.87% | |||
| EPS Diluted | 0.00% | 152.41% | |||
| Normalized Diluted EPS | -1.83% | 154.87% | |||
| Average Basic Shares Outstanding | 0.38% | 0.96% | |||
| Average Diluted Shares Outstanding | 4.45% | 0.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||